Organogenesis

About Organogenesis

Organogenesis Holdings Inc. is a regenerative medicine company that develops, manufactures, and commercializes advanced wound care and surgical products. Its portfolio includes bioengineered skin substitutes, placental allografts, antimicrobial barriers, and tissue scaffolds for the treatment of chronic and acute wounds, burns, and soft tissue injuries. The company serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician offices, primarily in the United States. Organogenesis Holdings Inc. is headquartered in Canton, Massachusetts.